caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1669536629

Dennis KayM.D.

OphthalmologyDallas, TXI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Dennis Kay's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 10 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Laboratory Corporation Of America
Clinical Laboratory · Dallas, TX
5081
BAYLOR UNIVERSITY MEDICAL CENTER4756
Clinical Pathology Laboratories, Inc.
Clinical Laboratory · Austin, TX
2634
UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER AT DALLAS2447
TEXAS HEALTH PRESBYTERIAN HOSPITAL DALLAS2229
FULLER, DWAIN1743
Swdic Imaging Center Partnership, Llp
Independent Diagnostic Testing Facility (IDTF) · Dallas, TX
1636
Scott Bates
Anesthesiology · Dallas, TX
1327
Jennifer Kirkpatrick Arnette
Anesthesiology · Dallas, TX
1227
William Christensen
Internal Medicine · Dallas, TX
1239
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
739
Beneficiaries
—
Total drug cost
$20K
Distinct drugs
10
Brand share
22.2%
Top prescribed drugs
Latanoprost326 claims
Moxifloxacin Hcl96 claims
Prednisolone Acetate83 claims
Dorzolamide Hcl/Timolol Maleat44 claims
Ciprofloxacin Hcl41 claims
QUALITY · MIPS · 2024
Final MIPS score
88.0
Quality
91.3
Cost
71.6
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.55%
Individual
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
3,684
Unique beneficiaries
—
Total services
3,890
Distinct HCPCS
14
Medicare payment
$190K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 1,238 Ophthalmology providers in TX — above median (cohort median 1,864).